These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8426122)
1. Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes. Honeyman MC; Cram DS; Harrison LC J Exp Med; 1993 Feb; 177(2):535-40. PubMed ID: 8426122 [TBL] [Abstract][Full Text] [Related]
2. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes. Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878 [TBL] [Abstract][Full Text] [Related]
3. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Harrison LC; Honeyman MC; DeAizpurua HJ; Schmidli RS; Colman PG; Tait BD; Cram DS Lancet; 1993 May; 341(8857):1365-9. PubMed ID: 8098789 [TBL] [Abstract][Full Text] [Related]
4. Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Elliott JF; Qin HY; Bhatti S; Smith DK; Singh RK; Dillon T; Lauzon J; Singh B Diabetes; 1994 Dec; 43(12):1494-9. PubMed ID: 7525393 [TBL] [Abstract][Full Text] [Related]
5. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Rudy G; Stone N; Harrison LC; Colman PG; McNair P; Brusic V; French MB; Honeyman MC; Tait B; Lew AM Mol Med; 1995 Sep; 1(6):625-33. PubMed ID: 8529129 [TBL] [Abstract][Full Text] [Related]
6. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. Atkinson MA; Bowman MA; Campbell L; Darrow BL; Kaufman DL; Maclaren NK J Clin Invest; 1994 Nov; 94(5):2125-9. PubMed ID: 7962558 [TBL] [Abstract][Full Text] [Related]
7. Glutamic acid decarboxylase-67 (GAD67): expression relative to GAD65 in human islets and mapping of autoantibody epitopes. Cram DS; Faulkner-Jones B; Kun J; Harrison LC Endocrinology; 1995 Mar; 136(3):1111-9. PubMed ID: 7532577 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile. Schmidli RS; DeAizpurua HJ; Harrison LC; Colman PG J Autoimmun; 1994 Feb; 7(1):55-66. PubMed ID: 8198702 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356 [TBL] [Abstract][Full Text] [Related]
11. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes. De Aizpurua HJ; Wilson YM; Harrison LC Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9841-5. PubMed ID: 1409709 [TBL] [Abstract][Full Text] [Related]
12. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays. Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395 [TBL] [Abstract][Full Text] [Related]
13. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex. Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414 [TBL] [Abstract][Full Text] [Related]
14. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. Endl J; Otto H; Jung G; Dreisbusch B; Donie F; Stahl P; Elbracht R; Schmitz G; Meinl E; Hummel M; Ziegler AG; Wank R; Schendel DJ J Clin Invest; 1997 May; 99(10):2405-15. PubMed ID: 9153283 [TBL] [Abstract][Full Text] [Related]
15. Transcription factor jun-B is target of autoreactive T-cells in IDDM. Honeyman MC; Cram DS; Harrison LC Diabetes; 1993 Apr; 42(4):626-30. PubMed ID: 8454114 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. Panina-Bordignon P; Lang R; van Endert PM; Benazzi E; Felix AM; Pastore RM; Spinas GA; Sinigaglia F J Exp Med; 1995 May; 181(5):1923-7. PubMed ID: 7722468 [TBL] [Abstract][Full Text] [Related]
17. T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects. Schloot NC; Roep BO; Wegmann DR; Yu L; Wang TB; Eisenbarth GS Diabetologia; 1997 Mar; 40(3):332-8. PubMed ID: 9084973 [TBL] [Abstract][Full Text] [Related]
18. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. Wicker LS; Chen SL; Nepom GT; Elliott JF; Freed DC; Bansal A; Zheng S; Herman A; Lernmark A; Zaller DM; Peterson LB; Rothbard JB; Cummings R; Whiteley PJ J Clin Invest; 1996 Dec; 98(11):2597-603. PubMed ID: 8958223 [TBL] [Abstract][Full Text] [Related]
19. Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin. Griffin AC; Zhao W; Wegmann KW; Hickley WF Am J Pathol; 1995 Sep; 147(3):845-57. PubMed ID: 7545875 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives. Chen QY; Rowley MJ; Byrne GC; Jones TW; Tuomi T; Knowles WJ; Zimmet PZ; Mackay IR Pediatr Res; 1993 Dec; 34(6):785-90. PubMed ID: 8108194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]